This review provides a comprehensive overview of the epidemiology, etiology, pathogenesis, and management of aneurysmal coronary artery disease.
Answers are grounded in this paper and cite their sources.
Management of ACAD remains controversial; leaves open the need for prospective trials to define optimal strategies.
Aneurysmal coronary artery disease (ACAD) comprises both coronary artery aneurysms (CAA) and coronary artery ectasia (CAE). The reported prevalence of ACAD varies widely from 0.2 to 10%, with male predominance and a predilection for the right coronary artery (RCA). Atherosclerosis is the commonest cause of ACAD in adults, while Kawasaki disease is the commonest cause in children and adolescents, as well as in the Far East. Most patients are asymptomatic, but when symptoms do exist, they are usually related to myocardial ischemia. Coronary angiography is the mainstay of diagnosis, but follow up is best achieved using noninvasive imaging that does not involve exposure to radiation. The optimal management strategy in patients with ACAD remains controversial. Medical therapy is indicated for the vast majority of patients and includes antiplatelets and/or anticoagulants. Covered stents effectively limit further expansion of the affected coronary segments. Surgical ligation, resection, and coronary artery bypass grafting are appropriate for large lesions and for associated obstructive coronary artery disease.
No takes yet. Share an insight, caveat, or question.
ElGuindy et al. (2018) conducted a review in Aneurysmal coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: